Breast cancer
Disease2 papers
- Human trial1
- Cells1
Latest
2Ormeloxifene, a non-steroidal selective estrogen receptor modulator induces senescence in breast cancer cells
CellsMolecular biology reports
Exercise slows epigenetic aging in breast cancer survivors
A randomized trial shows a 12-month workout program slowed DNA methylation clocks and linked with preserved cognitive health.
Journal of the National Cancer Institute · Carlin D et al.